Western Australia – November 02, 2026 -- Rio Tinto is pitching a portfolio of iron ore, copper and aluminium to investors as demand rises from AI, digital infrastructure and electrification, backed by operations in 35 countries and a workforce of more than 60,000.

TAMPA – October 27, 2026 -- Akari Therapeutics (Nasdaq: AKTX) plans to begin Phase 1 clinical development of its lead antibody drug conjugate, AKTX-101, in mid-2027, with the compound now moving through IND-enabling toxicology and safety studies and large-scale GMP manufacturing.

CEO Abizer Gaslightwala laid out the strategy in a new CEO Corner segment. He argues that payload differentiation will matter more as ADCs move into front-line therapy and patients develop resistance to current payload classes, leaving few follow-on options.

Toronto – October 12, 2026 -- Highlander Silver Corp. (TSX, NYSE American: HSLV) held about US$100 million in unaudited cash and no debt as of March 31 and forecasts a year-end cash balance of roughly US$60 million, according to its first portfolio update since completing the combination with Bear Creek Mining.

Vancouver – October 01, 2026 -- Graphite One Inc. (TSXV: GPH) (OTCQX: GPHOF) has created a new advanced systems division targeting graphite applications in defense, space and national security markets, while disclosing roughly US$1.58 million in new investor-relations marketing contracts.